February 23, 2024 is the week of the 5th .......................................................................................

Under the effect of multiple positives, the rising index has been 7 consecutive yangs, which is the first time in the past three and a half years..................................................

If there are 7 consecutive yangs, it is possible that there are 8 consecutive yangs..............................................................................................

In short, the current market is stable, and individual stocks with special themes continue to rise................................ Among them, the leader of the new quality productivity was already 10 consecutive yangs yesterday, and today we will see if it is 11 consecutive yangs?

The leading stocks in AI have risen from $17.33 in five days to $43.06 at yesterday's close.................................. Let's see if it can still go up today?

...................................................

Through the review, Yuansheng found a low-priced theme stock, please see its theme---------------------------

Investors: What is the level of the company's smart healthcare in China?

The company replied: Dear investors, after years of accumulation, the company has become a well-known smart medical overall solution service provider in China, is the first medical information enterprise in China to provide overseas hospitals with overall information construction services in line with international standards, and is also one of the few IT companies in China that can provide certification consulting services such as electronic medical record rating review and hospital information interconnection evaluation at the same time. The technical architecture of the intelligent open platform developed by the company provides an important platform architecture foundation for carrying out accessible and coherent medical and health services and promoting the transformation of domestic medical information construction mode. The company has independently formulated and applied for several international standards for medical informatization, such as ISO/PRFTS22990 "Chinese Framework of Clinical Terminology System of Traditional Chinese and Western Medicine", achieving a new breakthrough in the field of international medical standards in China. The company is the first company in China to pass Kube

ETES Cloud Native Solutions and de facto standard certified vendors specializing in medical business software development. Looking forward to the future, the company will continue to rely on the five core technologies of "Internet of Things, artificial intelligence, platform big data interaction, microservice architecture, and blockchain", strengthen the core advantages in the field of Internet + Internet of Things, build a new model of ubiquitous smart medical and health services driven by data, and continue to lead the innovation and development of the industry. Thank you for your interest in the company!

Investors: What is the layout of the company in terms of computing power? In terms of cloud computing, how much computing power does the company have, and what R&D does the company currently do in terms of AI artificial intelligence?

The company's reply: Dear investors, the single-disease artificial intelligence service system developed by the company is a new business line of artificial intelligence services based on single-disease data assets, and the research and development of the new business line is based on the transformation of single-disease data knowledge in medical institutions, the construction of single-disease resource library and the scientific application of single-disease data as the core, integrating advanced big data technology, artificial intelligence technology and blockchain technology. Based on the THINKGO medical artificial intelligence cognitive engine with independent intellectual property rights, it has developed and accumulated more than 60 single-disease data resource libraries and data science application service platforms. Among them, the THINKGO medical artificial intelligence cognitive engine has the ability to automate the whole life cycle of data, the engineering transformation and aggregation of knowledge capabilities, and the output of multimodal cognitive capabilities, realizing the ability of the whole chain from data processing, knowledge engineering to AI capability output. With the help of THINKGO medical artificial intelligence cognitive engine, the construction of a data resource library platform for more than 60 common diseases has been completed, and a special disease cohort has been developed and constructed simultaneously, and the construction of platforms and toolsets related to multi-center clinical research has been carried out. The data science application service platform is an application platform developed on the basis of THINKGO medical artificial intelligence cognitive engine and single-disease data resource library, and has developed and completed clinical application-oriented clinical knowledge base, CDSS clinical assisted decision-making, clinical assistant robot, single disease/specialty scientific research system and other applications. Management-oriented DRGs single disease analysis, medical insurance cost control, refined management and other applications; Applications such as research cohorts, real-world and multicenter studies for scientific research. Thank you for your interest in the company!

It's just trying to create stocks..........................................................

In the morning, the stock opened 0.68% higher, and Yuansheng was waiting....................................

At 9:33, when the stock retreated to 2.85 yuan, Yuansheng decisively continued to buy...................................................... In the end, the cost was controlled at 2.90 yuan and the battle of the first battlefield of this expansion of territory ended.

The second battlefield is the battle of Kokuwei stock. In the morning, Guowei stock opened 14.98% higher, and Yuansheng was waiting...........................................

After the stock price fluctuated at 9:30, when Guowei's stock retreated to 6.20 yuan in less than a minute, Yuansheng decisively increased its position......................................

At 9:34, Guowei stock quickly rose to the limit, and Yuansheng decisively cleared the chips bought yesterday at the price of 6.89 yuan: it was bought at 4.90 yuan yesterday, and it was sold at 6.89 yuan for 1 night, earning 40.6%, which is already a very huge profit..................................................

.............................

Yuansheng took stock of the stocks in his hand: I want to create a stock price limit, and Guowei stock price limit.

PS: Stock prototype for today's clearance: None